Haemonetics Corp. (HAE) Misses Q4 EPS by 3c; Guides FY13 EPS Below Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $125.00 +3.92%
Revenue Growth %: +5.6%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
ATS, SICP, FTCO, More
Revenue Growth %: +5.6%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q4 EPS of $0.80, $0.03 worse than the analyst estimate of $0.83. Revenue for the quarter came in at $186.7 million versus the consensus estimate of $183.09 million.
Haemonetics Corp. sees FY2013 EPS of $3.30-$3.40, versus the consensus of $3.50.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Haemonetics Corp. sees FY2013 EPS of $3.30-$3.40, versus the consensus of $3.50.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CPS Technologies (CPSH) Reports In-Line Q3 EPS
- Intel shares fall as competitor reports record results
- SharkNinja (SN) Tops Q3 EPS by 74c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
